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The endoplasmic reticulum (ER) represents the entry point into the secretory pathway and from 22 
here newly synthesized proteins and lipids are delivered to the Golgi. The selective cargo export 23 
from the ER is mediated by COPII-assembly at specific sites of the ER, the so-called transitional ER 24 
(tER). The peripheral membrane protein Sec16, first identified in yeast, localizes to transitional ER 25 
and plays a key role in organization of these sites. Sec16 defines the tER and is thought to act as a 26 
scaffold for the COPII coat assembly. In humans two isoforms of Sec16 are present, the larger 27 
Sec16A and the smaller Sec16B. Nevertheless, the functional differences between the two isoforms 28 
are ill-defined. Here we describe characterization of the localization and dynamics of Sec16B relative 29 
to Sec16A, provide evidence that Sec16B is likely a minor or perhaps specialized form of Sec16, and 30 
that it is not functionally redundant with Sec16A.   31 
 32 
33 
3 
 
The organization of COPII dependent budding is very different between some of the key species. In 34 
mammalian cells and the yeast Pichia pastoris budding of COPII-coated vesicles occurs at specific 35 
sites of the ER, the transitional ER 1, 2. These subdomains are regions of rough ER, which are devoid 36 
of ribosomes and show characteristic COPII positive buds 2, 3. The tER membrane together with the 37 
first post-ER membrane structures, which are prior to fusion with (or to become) the ERGIC make up 38 
the so-called ER exit site (ERES, reviewed in 4). Several hundred ERES, which are distributed 39 
throughout the cytoplasm with an accumulation at the juxtanuclear region, can be found in 40 
mammalian cells 1. Time-lapse imaging reveals them to be relatively long-lived structures 5, 6.  41 
COPII vesicle budding in vivo requires the peripheral membrane protein Sec16p. SEC16 gene was 42 
first identified in Saccharomyces cerevisiae 7; SEC16 mutations result in a lack of 50 nm vesicles in 43 
these mutants 8. Sec16p localizes to the ER membrane and has three main functional domains 44 
namely the central conserved domain (CCD), the N-terminal domain and the C-terminal domain, 45 
which are separated by clusters of proline rich regions 9. Protein interaction assays showed that 46 
Sec16p interacts with multiple COPII subunits; Sec24p and Sec31p bind Sec16p at the CCD, whereas 47 
Sec23p interacts with the C-terminus 9-11. These results suggest a key involvement of Sec16p in the 48 
formation of COPII-coated vesicles, possibly by acting as a scaffold for the assembly of the COPII 49 
coat. In vitro, Sec16p facilitates the recruitment of Sec23/24p and Sec13/31p to synthetic liposomes 50 
12. Additionally, Sec16p stabilizes the Sec23/24p-Sar1p-GTP complex on liposomes, which could be 51 
achieved by preventing its premature disassembly after GTP-hydrolysis.  52 
Database search of the human genome using the CCD of the yeast Sec16p identified two mammalian 53 
orthologues of yeast Sec16p – a longer Sec16A and a shorter Sec16B 13-15. Overexpression and siRNA 54 
depletion showed the involvement of mammalian Sec16A in ERES organization. In both cases, a 55 
disorganization of the ERES was observed as the number ERES in the cell periphery as well as in the 56 
juxtanuclear region decreased 13, 14. In addition to that, depletion of Sec16A resulted in a delay and 57 
over-expression in an inhibition ER-to-Golgi transport 13-15.  58 
Pull-down assays revealed a physical interaction of Sec16A with the COPII subunits Sec23 and Sec13, 59 
which is in line with the idea that Sec16 functions as a platform for COPII assembly 14, 15. 60 
Fluorescence recovery after photobleaching (FRAP) analysis showed that YFP-Sec16A rapidly cycles 61 
on and off the membrane 13, although there is a significant steady-state pool of Sec16A in the 62 
cytoplasm, FRAP analysis revealed that Sec16A has a greater half-life (~ 6 sec) than other COPII 63 
components such as Sec23A or Sec24D (both ~ 4 sec) 16, 17. Moreover, Sec16A has a greater immobile 64 
pool (around 40%) on the ER membrane compared to Sec23A (around 20%), suggesting that 65 
recycling of Sec16A is slower than that of other COPII components 16. This is consistent with the idea 66 
that Sec16A provides a platform for the assembly of the COPII.  67 
Recently, laser scanning confocal microscopy and electron microscopy was used to define the 68 
steady-state localization of human Sec16A in more detail 16. Confocal microscopy and immunogold 69 
labelling of ultrathin cryosections showed that Sec16A localizes to sites adjacent to Sec31A. Electron 70 
tomography showed that Sec16A localized to concave cup-shaped structures, but it remains unclear 71 
if Sec16A is involved in generating this curvature or sensing curved membranes. 16. Consistent with 72 
its role in organizing COPII assembly, the localization of Sec16A to ERES was shown to be 73 
independent from other COPII components as Sec16A remained associated with the tER membrane 74 
in the absence of Sec23/24 and Sec13/31 16. Whether Sec16A plays a regulatory or structural role in 75 
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COPII assembly remains to be determined; these possibilities are of course not mutually exclusive. 76 
Consistent with a role in regulating assembly Sec16p in P. pastoris is found at significantly lower 77 
abundance when compared to COPII proteins 18. It is not fully understood whether Sec16A becomes 78 
incorporated into vesicles or is only exchanged between a membrane bound pool and a cytosolic 79 
pool. S. cerevisiae Sec16p for example was shown to be incorporated into budded vesicles in vitro 80 
and electron micrographs revealed Sec16A labelled structures that were consistent with COPII 81 
vesicles 9, 16. It would therefore be possible, that Sec16 is incorporated transiently into COPII-coated 82 
vesicles 16.  83 
The  Drosophila melanogaster orthologue of Sec16, dSec16 19 shares 23% amino acid identity with 84 
human Sec16A with the highest conservation in the C-terminal domain and the CCD. The peripheral 85 
membrane protein dSec16 also localizes to ERES and in agreement with the findings for human 86 
Sec16, depletion of dSec16 resulted to a disruption of ERES as shown by immunofluorescence and 87 
electron microscopy. Conversely, an ER-to-plasma membrane transport assay using plasma 88 
membrane marker Delta and the Golgi marker Fringe-GFP revealed that upon depletion of dSec16 89 
ER export was inhibited 19. As shown for human Sec16A, dSec16 localized to cup-shaped structures 90 
on the ER, which was determined by immuno-EM. Moreover, investigation of dSec23 depleted cells 91 
by immuno-EM revealed that dSec16 still localized to the tER in the absence of dSec23. These results 92 
suggest that dSec16 localizes upstream of other COPII subunits confirming the results obtained for 93 
human Sec16A 16, 19. Taken together, Sec16 seems to play an important role in the organization of 94 
ERES and seems to act as a scaffold for the assembly of the COPII coat. Sec16 orthologues have been 95 
identified in all species tested so far, including for example Mus musculus (mouse), Gallus gallus 96 
(chicken) and Danio rerio (zebrafish) underlining the importance of Sec16 in ER-to-Golgi transport 15. 97 
Many species contain two isoforms (including mammals) while some only have one isoform, as for 98 
example C. elegans and Drosophila. However, the distinct functions of the two Sec16 isoforms 99 
remain elusive.  100 
The role of the second mammalian ortholog Sec16B is less well defined 15. The 117 kD protein has 101 
been previously described as a regucalcin gene promoter region-related protein(RGPR-p117, 102 
reviewed in 20). A GFP-tagged version of Sec16B was shown to localize to ERES and siRNA depletion 103 
of Sec16B resulted in a disruption of ERES as seen for Sec16A 21, 22. Moreover, Sec16B is required for 104 
export from the ER as cells depleted of Sec16B showed an inhibition of GalNAc-T2-GFP transport 105 
from the ER 15. Sec16A and Sec16B were shown to co-immunoprecipitate and thus likely function in 106 
a heteromeric complex 15. Here we have used a combination of approaches that reveal Sec16B to be 107 
a minor isoform in terms of expression profile and also provide evidence that Sec16B cannot 108 
compensate for loss of Sec16A function in cells. Our data point to an as yet undefined specialized 109 
role for Sec16B in human cells.  110 
111 
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Results: 112 
Characterization of anti-Sec16B antibodies 113 
In order to identify endogenous Sec16B and further investigate its functions, we sought to generate 114 
specific antibodies against human Sec16B. We generated and affinity purified three different anti-115 
peptide antibodies, anti-Sec16B (996-1010), anti-Sec16B (883-897), and anti-Sec16B (393-408). The 116 
peptides were designed against unique sequences of Sec16B, so that no cross-reaction of the 117 
antibodies with Sec16A could occur. In order to determine if the antibodies are able to detect 118 
endogenous Sec16B by western blotting, several cell types were lysed and the proteins separated by 119 
SDS-PAGE. Moreover, the three antibodies were tested for specificity on HeLa cells overexpressing 120 
GFP-Sec16B . The results are shown in Figure 1A-C. All three antibodies detected over-expressed 121 
GFP-Sec16B, which has a molecular weight of ~ 144 kD (Figure 1A, B and C, lane 1 #). 122 
Immunoblotting with anti-Sec16B (393-408) detected multiple protein bands, with some very faint 123 
bands at around 100 kD (Figure 1A). Immunoblotting with anti-Sec16B (883-897) revealed a number 124 
of protein bands, including three bands at around 100 kD (Figure 1B). None of the bands detected in 125 
HeLa cells were lost upon siRNA-mediated suppression of Sec16B (data not shown). The antibody 126 
anti-Sec16B (996-1010) detected a single band at ~ 60 kD (Figure 1C). This protein does not have the 127 
molecular weight expected for Sec16B (~ 117 kD) and was also unaffected by siRNA depletion of 128 
Sec16B in HeLa cells (data not shown).  129 
To test the specificity of the antibodies on over-expressed Sec16B by immunofluorescence, HeLa 130 
cells were transfected with GFP-Sec16B, methanol fixed 16 hours after transfection and stained with 131 
the antibodies anti-Sec16B (393-408), anti-Sec16B (996-1010), and anti-Sec16B (883-897). The 132 
antibody anti-Sec16B (393-408), however, was unable to detect GFP-Sec16B by immunofluorescence 133 
(Figure 1D). Two of the three antibodies, anti-Sec16B (883-897) and anti-Sec16B (996-1010), 134 
recognized over-expressed GFP-Sec16B. Defined labelling of GFP-Sec16B marked ERES with the 135 
antibodies was observed (Figure 1E and 1F, arrows). These antibodies were further tested on 136 
different cell types, NHDF and C13NJ cells (Figure 1G-J). Cells were methanol fixed and double 137 
labelled with the antibodies anti-Sec16B (883-897) and anti-Sec31A or anti-Sec16B (996-1010) and 138 
anti-Sec24C. The antibodies anti-Sec16B (883-897) and anti-Sec16B (996-1010) both detected some 139 
puncta in NHDF cells (Figure 1G, 1H). However, these did not localize adjacent to Sec31A or Sec24C 140 
and are therefore not ERES (Figure 1G, 1H, arrows). Therefore, these puncta do not represent ERES 141 
and are more likely accumulated antibody or non-specific staining. In C13NJ cells both antibodies 142 
showed unspecific cytosolic staining (Figure 1I and J). Similar results were obtained in SH-SY5Y cells. 143 
Both antibodies showed an overall diffuse staining and anti-Sec16B (883-897) also detected puncta, 144 
but these were distinct from Sec31A labelling indicating that they are not bona fide ERES (data not 145 
shown). We conclude that the three antibodies tested – anti-Sec16B (996-1010), anti-Sec16B (393-146 
408) and anti-Sec16B (883-897) – did not detect endogenous Sec16B by immunofluorescence or 147 
western blotting. Thus, either those cell types examined do not express Sec16B, or the antibodies 148 
are not of sufficient avidity to detect a very low level of endogenous expression of Sec16B.   149 
Effects of siRNA depletion of endogenous Sec16B 150 
Depletion of endogenous Sec16B was previously described to result in a disruption of ERES and the 151 
Golgi as well as a block of ER-to-Golgi transport 15, similar to the phenotype observed in Sec16A 152 
depleted cells 13-15. We depleted Sec16B in HeLa cells using siRNA in order to verify the previously 153 
6 
 
described phenotype 15. Here we used the same siRNA sequence (termed here Sec16B “G”). Using 154 
immunoblotting or transfection of cells expressing GFP-Sec16B, we confirmed that isoform 155 
specificity of these siRNAs. RPE-1 cells expressing GFP-Sec16B were transfected with the siRNA 156 
Sec16B “G”, and Sec16B UTR, which targets Sec16B in the 3’ untranslated region. Figure 2 shows 157 
that these siRNAs are effective against GFP-Sec16B in stably transfected RPE-1 cells. Sec16B UTR is 158 
ineffective in this assay at it targets a sequence within the non-coding region that was not included 159 
in the construct used to generate this cell line. We then sought to determine the effect of depleting 160 
Sec16B on early secretory pathway function. In addition to depletion of Sec16B alone, Sec16A and 161 
Sec16B were depleted simultaneously by adding both siRNAs Sec16B “G” and Sec16A UTR to the 162 
cells (Figure 3A-D). 72 hours after transfection the cells were methanol fixed and double stained with 163 
an anti-Sec24C and anti-ERGIC-53 antibody. When compared to the control GL2 (Figure 3A), Sec16A 164 
depleted cells showed a reduction of Sec24C labelled ERES (Figure 3B). Sec16A depletion also 165 
induced a redistribution of ERGIC-53 to an overall ER-like pattern (Figure 3B) compared to the 166 
control cells (Figure 3A). By contrast, transfection with duplexes targeting Sec16B had no effect on 167 
Sec24C or ERGIC-53 (Figure 3C). Significantly, targeting both, Sec16A and Sec16B (Figure 3D), 168 
resulted in an indistinguishable phenotype to that observed on suppression of Sec16A alone (Figure 169 
3B). Cells showed a reduced number of ERES and an ER-like distribution of ERGIC-53 (Figure 3D).  170 
Subsequently, we set out to investigate whether GFP-Sec16B could compensate for loss of function 171 
of Sec16A.  As we could not detect Sec16B expression in cell lines, we generated two cell lines stably 172 
expressing GFP-Sec16B for further characterization. GFP-Sec16B was amplified by PCR and cloned 173 
into the lentiviral expression vector pLVX-puro as described in 23. HeLa and RPE-1 cells were 174 
subsequently transduced with the virus and stably expressing cells were selected with puromycin. 175 
Immunoblotting with an anti-GFP antibody revealed that in both cell lines GFP-Sec16B was 176 
expressed as a correct fusion protein having a molecular weight of ~ 144 kD (data not shown). In 177 
order to determine the correct cellular localization of GFP-Sec16B, HeLa GFP-Sec16B cells and RPE-1 178 
GFP-Sec16B cells were first imaged live. In both cell lines GFP-Sec16B localized to puncta which were 179 
distributed throughout the cell in an ERES-like pattern that showed mainly short range movements 180 
(data not shown) consistent with other ERES markers 13, 24.  HeLa GFP-Sec16B cells were then 181 
transfected with siRNA duplexes targeting Sec16A as well as two control siRNAs. Immunoblotting of 182 
GFP-Sec16B cells transfected with control siRNA duplexes for 72 hours showed no effect on Sec16A 183 
expression (Figure 3E). Sec16A was effectively suppressed with the siRNA used and this was not 184 
affected by the presence of GFP-Sec16B. Of note, GFP-Sec16B expression was slightly reduced 185 
following suppression of Sec16A. There is no significant homology between the duplex used to 186 
target Sec16A here and the sequence of Sec16B, so we believe this reflects the fact that Sec16A is 187 
required to stabilize GFP-Sec16B. Immunofluorescence using these cells showed that suppression of 188 
Sec16A resulted in a loss of peripheral ERES (Sec31A labelling, Figure 3G compared to Figure 3F). 189 
Compared to control cells (Figure 3H), a redistribution of ERGIC-53 to a more ER-like distribution was 190 
observed in Sec16A depleted cells (note enhanced nuclear envelope labelling and reduction in 191 
number of peripheral puncta, Figure 3I). Thus, depletion of Sec16A in HeLa GFP-Sec16B cells had the 192 
same effect on other components of the secretory pathway as in wild type HeLa cells indicating that 193 
loss of Sec16A was not compensated by the presence of GFP-Sec16B. Thus, neither endogenous nor 194 
overexpressed GFP-Sec16B can compensate for loss of Sec16A.    195 
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Localization of GFP-Sec16B and COPII proteins analyzed by high resolution light microscopy 196 
HeLa GFP-Sec16B cells were processed for immunofluorescence to determine the degree of 197 
colocalization of GFP-Sec16B with ERGIC markers. We showed previously that Sec16A localizes to the 198 
tER clearly distinct from the ERGIC 23. Cells were imaged at the highest possible resolution allowed 199 
by conventional laser scanning microscopy ensuring that the Nyquist sampling theorem was satisfied 200 
and no pixels were saturated. Figure 4A shows that, GFP-Sec16B clearly colocalizes with Sec16A and 201 
localizes offset from markers of the ERGIC, ERGIC-53 (Figure 4B) and β’-COPI (Figure 4C). These 202 
results show that GFP-Sec16B localizes to ERES, most likely the tER, in both HeLa and RPE-1 cells.  203 
During the analysis of the stable GFP-Sec16B cell lines a very minor population of GFP-Sec16B 204 
expressing cells were observed to show GFP fluorescence in the nucleus. When RPE-1 GFP-Sec16B 205 
cells were imaged, in a subset of cells GFP-Sec16B could be found diffusely distributed throughout 206 
the nucleus with localization to some brighter puncta (Figure 4D, arrows). That this distribution is 207 
evident during live cell imaging (Figure 4D) shows that this is not an artefact of fixation. Methanol 208 
fixation of RPE-1 GFP-Sec16B cells extracted the diffuse staining revealing a punctate localization of 209 
GFP-Sec16B within the nucleus (Figure 4E, F). When RPE-1 GFP-Sec16B cells were fixed with 210 
paraformaldehyde (PFA) the nuclear staining resembled that observed in living cells showing a few 211 
brighter punctae in an overall diffuse stained nucleus (data not shown). This is likely to be because 212 
PFA fixation does not extract the soluble fraction of GFP-Sec16B. Immunostaining for the protein 213 
Coilin, the main component of the nuclear localized Cajal bodies 25 and the promyelocytic leukemia 214 
protein (PML), a transcription factor present in PML bodies within the nucleus 26, showed no 215 
colocalization of the GFP-Sec16B labelled punctae with Coilin (Figure 4E) or PML (Figure 4F). In order 216 
to quantify the number of cells with nuclear localization of GFP-Sec16B, cells with typical ERES 217 
localization and nuclear localization of GFP-Sec16B were counted. Nuclear localization of GFP-218 
Sec16B was found in less than 0.1% of cells (n>600). 219 
Requirements for tER localization of Sec16B 220 
We and others have defined the minimal region of Sec16A required for efficient targeting of the 221 
protein to the tER as comprising the central conserved domain (CCD) along with an adjacent 222 
upstream sequence 23, 27. To further investigate the targeting requirements of Sec16B, the complete 223 
tER localization domains as well as four fragments of each of these domains were N-terminally 224 
tagged with GFP (Figure 5). The complete tER localization domain constructs were designed 225 
according to the published sequences 15 and only minor variations were undertaken: four additional 226 
amino acids upstream of the original tER localization domain of Sec16A and one amino acid 227 
downstream of the tER localization domain of Sec16B were included for the constructs used here. 228 
These additional amino acids show a high conservation among various species and could therefore 229 
be involved in the targeting process. Figure 5A shows a schematic of the constructs investigated 230 
here.  GFP-tagged constructs were transfected into HeLa cells and imaged in living as well as fixed 231 
cells. Immunoblotting confirmed that the constructs resulted in expression of protein of the 232 
expected size without significant degradation (data not shown). The control GFP-Sec16B showed a 233 
distinct ERES pattern when imaged in living and fixed cells (Figure 5B and C, first panel). The GFP-234 
tagged construct containing the complete tER localization domain GFP-Sec16B (34-235), however, 235 
was distributed throughout the cytoplasm and the nucleus (Figure 5B and C). A similar localization 236 
was observed for the four fragments of the tER localization domain of Sec16B – GFP-Sec16B (34-237 
109), GFP-Sec16B (34-159), GFP-Sec16B (159-235) and GFP-Sec16B (109-235). In very few cells a 238 
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diffuse punctate pattern could be observed after fixation, for example, for the construct GFP-Sec16B 239 
(109-235) (Figure 5C, #). These puncta did not resemble ERES and did not label with Sec24C or 240 
Sec31A (data not shown) and are therefore non-specific and could be fixation artefacts, or represent 241 
aggregated protein. In summary, none of the GFP-tagged tER localization domain constructs 242 
designed here localized to ERES and we conclude that the requirement for accurate localization of 243 
Sec16B to ERES are the same as those for Sec16A 23, namely the CCD and immediate upstream 244 
sequence.  245 
Identification of interaction partners of Sec16B 246 
In order to identify other interaction partners of Sec16B, HeLa GFP-Sec16B cells and HeLa control 247 
cells transfected with pEGFP-C2 were lysed and a large scale immunoprecipitation carried out. GFP-248 
Sec16B and the proteins bound to Sec16B were extracted from whole cell lysate using the GFP-Trap®. 249 
Subsequently, the beads fraction was separated by SDS-PAGE on a 5% and 15% gel and the proteins 250 
which were bound to GFP-Sec16B visualized with SYPRO® Ruby (Figure 6A and B). GFP-Sec16B could 251 
be determined by its size of ~ 144 kD on the 5% gel (Figure 7B, #). By comparison with bands present 252 
in the GFP control, three distinct bands of the 15% gel were chosen for further identification by mass 253 
spectrometry (Figure 6A, arrows). The three proteins were extracted from the 15% gel, digested and 254 
the peptides analyzed by MS/MS spectrometry. The proteins were then identified by blast search 255 
against a human database. Band 1 was determined to be the heat shock 70 kD protein 8 (HSPA8) or 256 
heat shock cognate 70 (Hsc70). Bands 2 and 3 were both identified as Sec13. The interaction with 257 
Sec13 was validated by immunoblotting (Figure 6C). Again, as a control, HeLa cells transfected with 258 
pEGFP-C2 were used. 1% of input and unbound fraction as well as 20% of the beads were separated 259 
by SDS-PAGE. Incubation with an anti-GFP antibody showed that GFP as well as GFP-Sec16B (~ 144 260 
kD) efficiently bound to the GFP-Trap® beads (Figure 6C, top row, lane 2 and 5, #). Immunoblotting 261 
for various COPII components revealed that GFP-Sec16B binds to Sec13 (Figure 6C, second row, lane 262 
5) and Sec16A (Figure 7C, bottom row, lane 5), but not to Sec31A (Figure 6C, third row, lane 5). 263 
These results are consistent with the idea that Sec16B functions in ER export through interaction 264 
with Sec16A and Sec13. Lack of detectable interaction with Sec31A is also consistent with the idea 265 
that Sec16B forms a direct complex with Sec13 through its central conserved domain 28. This domain 266 
forms an ACE (ancestral coat element) which interacts with Sec13 in a similar way to the integration 267 
of Sec13 into a complex with Sec31 and separately with nuclear pore complex 29. These findings are 268 
supported by the relatively high level of conservation of the central conserved domains (ACE 269 
domains) of Sec16A and Sec16B.   270 
 271 
272 
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Discussion: 273 
Analysis of various cell types by immunoblotting and immunofluorescence revealed that Sec16B 274 
protein is not detectable with any of the antibodies tested. Specificity of the antibodies, however, 275 
was proven by detection of over-expressed GFP-Sec16B. Consistent with this lack of detection, Q-276 
PCR using mRNA from different cell types showed that Sec16B expression is very low indeed in 277 
comparison to that of Sec16A (data not shown). Thus, it seems possible that Sec16B possesses a 278 
more specialized role within the cell and its function is only required at times of higher cargo load. 279 
Additionally, Sec16B could only be needed for transport of certain cargo molecules or at a specific 280 
cellular state. It is also possible that the expression of Sec16B is strictly regulated. 281 
Due to the inability to detect endogenous Sec16B, further characterization of Sec16B was performed 282 
using GFP-Sec16B. High resolution imaging revealed that GFP-Sec16B is found almost completely 283 
overlapping with Sec16A and, reminiscent of the localization of Sec16A itself, was found offset from 284 
rather than overlapping with COPI and ERGIC markers. Significantly, and in contrast to work 285 
published previously, our data following depletion of Sec16A in HeLa GFP-Sec16B cells suggested 286 
that Sec16A and Sec16B have non-redundant functions. Silencing of Sec16A in HeLa cells stably 287 
expressing GFP-Sec16B cells had the same effect as in control cells showing that the presence of 288 
GFP-Sec16B does not compensate for the loss of Sec16A. This apparent discrepancy from previously 289 
published data 15 could reflect a requirement for Sec16B that is only reflected in some assays and 290 
not others. This also supports the notion of a specialized function of Sec16B that we have yet to 291 
define.  292 
Our data support the idea that the CCD and immediate upstream sequence are both required for 293 
effective targeting of Sec16B to the tER. This is analogous to data obtained for the Sec16A isoform 23 294 
and is in line with recent findings by Rabouille and colleagues (2008) who showed that the minimal 295 
targeting region in Drosophila dSec16 consists of a non-conserved region upstream of the CCD, 296 
which includes several charged residues, as well as the CCD itself 19. Previous data implicated a 297 
smaller fragment of Sec16B (GFP-Sec16B (34-234)) in tER targeting; we only observed this at low 298 
expression level and in a minor population of cells; cell type and expression level differences could 299 
account for this. Overall, our data support a role for the CCD as well as upstream sequence in robust 300 
targeting of Sec16B to tER.  301 
In summary, these data provide strong evidence for a function of Sec16B at ERES. While we have 302 
been unable to characterize the endogenous protein, our data points to a specialized function for 303 
Sec16B linked to but perhaps distinct from that of Sec16A. It is possible that Sec16B possesses a 304 
more specialized role within the cell and perhaps its function is only required at times of higher 305 
cargo load. Sec16B could only be needed for transport of certain cargo molecules or at a specific 306 
cellular state; it is also possible that the expression of Sec16B is strictly regulated. GFP-Sec16B was 307 
also shown to interact with Sec16A and the COPII coat component Sec13 supporting the hypothesis 308 
that Sec16B functions in ER export. Fluorescence recovery after photobleaching also indicates that 309 
Sec16B (half-life of recovery of 5.7 seconds and 56% immobile fraction 22) is very similar in its 310 
dynamics of membrane association to Sec16A (half-life of recovery of 5.8 seconds and 43% immobile 311 
fraction 23) showing both a highly dynamic pool as well as substantial immobile component. Our own 312 
(unpublished) observations are in line with these findings. This is perhaps not surprising given the 313 
data showing that these two proteins form a complex.  314 
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We also show that GFP-Sec16B interacts with the COPII coat component Sec13 supporting further 315 
the hypothesis that Sec16B functions in ER export. Additionally, mass spectrometry revealed heat 316 
shock 70 kD protein 8, also known as heat shock cognate 70, as a potential interaction partner of 317 
Sec16B. Despite its function in protein folding, the ATPase Hsc70 is also involved in vesicle transport 318 
where it is required for the uncoating of clathrin-coated vesicles 30, 31. An interaction of Hsc70 with 319 
Sec16B could potentially be interesting and would require further verification as well as 320 
investigation. However, a true interaction between the two proteins is questionable as Hsc70 is 321 
known to be a common contaminant in immunoprecipitation assays using GFP-Trap® as it binds non-322 
specifically to the Sepharose matrix of the beads 32. We have no data to indicate that the binding of 323 
Hsc70 to Sec16B is anything other than a false positive result. 324 
Sec16B was first described as regucalcin gene promoter region-related protein (RGPR-p117) 325 
(reviewed in 20). Regucalcin is a Ca2+-binding protein that has been shown to exhibit multiple roles 326 
within the cell as for example in maintaining intracellular Ca2+ homeostasis, inhibition of protein 327 
kinases, protein phosphatases, protein synthesis as well as RNA and DNA synthesis (reviewed in 33). 328 
RGPR-p117 was shown to bind to the regucalcin promoter in a yeast one hybrid screen and 329 
overexpression of RGPR-p117 in NRK cells resulted in an increase of regucalcin mRNA levels. 330 
Moreover, HA-tagged RGPR-p117 was found to localize to the nucleus as well as the cytoplasm and 331 
to exhibit a putative leucine zipper motif, supporting the idea that the protein functions as 332 
transcription factor (reviewed in 20). Conversely, recombinant RGPR-p117 could not bind to the 333 
regucalcin promoter region in vitro. 20, 34. Interestingly, here we found that in very few cells stably 334 
expressing GFP-Sec16B a nuclear localization of GFP-Sec16B was observed. Together with the data 335 
described above suggesting that RGPR-p117/Sec16B functions as a transcription factor, one could 336 
speculate that Sec16B might have additional functions to those in ER-to-Golgi transport. Such an 337 
additional function as a transcription factor has been proposed for Sec12 35, 36. Sec12 was also 338 
identified as a putative prolactin regulatory element binding (PREB) transcription factor 36. Balch and 339 
co-workers suggested that Sec12/PREB could be released from the ER membrane in order to act as a 340 
transcription factor in a similar fashion as observed for the membrane bound transcription factors 341 
SREBPs  35. Such a regulated release from the ER could also be imagined for Sec16B. It cannot be 342 
excluded that GFP-Sec16B is simply proteolytically processed and that the degradation products 343 
enter the nucleus. 344 
The data shown here, however, provides strong evidence for a function of Sec16B in ER-to-Golgi 345 
transport. Sec16B was shown to interact with Sec13 and Sec16A, two proteins known to play key 346 
roles in ER export. The steady-state localization of Sec16B in relation to other early secretory 347 
pathway markers is similar to that observed for Sec16A 16 underlining a probable function of Sec16B 348 
in ER export. Analysis of protein and mRNA expression hints at some form of regulation of Sec16B 349 
expression and the possibility of a specialized role of Sec16B in protein transport.  350 
 351 
352 
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Methods:  353 
Production of polyclonal antibodies 354 
Peptide antibodies against Sec16B were raised against the following sequences: 355 
anti-Sec16B (393-408) (sheep) raised against aa 393-408 (CKKLEKYKRQPPVANL) 356 
anti-Sec16B (883-897) (rabbit) raised against aa 883-897 (CSDEADKNSPRNTAQR) 357 
anti-Sec16B (996-1010) (sheep) raised against aa 996-1010 (CGVGGLSGPESVSFEL) 358 
The rabbit anti-Sec16B antibody was produced by Eurogentec (Belgium). The two antibodies raised 359 
in sheep were produced by conjugation of peptides to keyhole limpet haemocyanin (KLH). 360 
Conjugates were used for immunization by the Scottish National Blood Transfusion Service 361 
(Penicuick, Scotland). Affinity purification was done using SulfoLink® coupling gel (Pierce). Peak 362 
fractions from the elution were combined. 363 
Antibodies used 364 
Antibodies used in this study were as follows. Anti-Sec24C and anti-β’-COP rabbit polyclonal 365 
antibodies generated in the Stephens lab and described previously 37; anti-giantin and anti-GFP 366 
(Covance, Cambridge UK), anti-ERGIC-53 (Sigma-Aldrich, Poole, UK), anti-Sec31A (Transduction labs, 367 
Cambridge, UK). Anti-coilin (Sigma-Aldrich) and anti-PML (Santa Cruz Biotechnology) were both 368 
kindly provided by Harry Mellor, anti-Sec13 antibodies were generous gifts from Wanjin Hong (IMCB, 369 
Singapore) and Beatriz Fontoura (Southwestern Medical Center, Dallas, TX), anti-Sec16A (anti-370 
KIAA0310, Bethyl Laboratories). Horseradish peroxidase (HRP)-conjugated secondary antibodies 371 
were from Jackson Laboratories (Suffolk, UK). Donkey anti-rabbit, anti-mouse, and anti-sheep 372 
secondary antibodies conjugated to Alexa Fluor dyes were from Molecular Probes (Invitrogen). 373 
Cell lines used 374 
Mammalian cell lines and primary cells were kindly provided by the following people: HeLa, hTERT-375 
RPE-1 human retinal pigment epithelial cells, and HEK 293T human embryonic kidney cell line 376 
(ATCC), HepG2 human hepatocellular liver carcinoma cell line (Giles Cory, University of Exeter), 377 
NHDF normal human dermal fibroblasts (ATCC), NRK normal rat kidney cell line (Jon Lane, University 378 
of Bristol), C13NJ human microglial cell line and SH-SY5Y human neuroblastoma cell line (both from 379 
Jeremy Henley, University of Bristol). HeLa cells, HEK 293T, SH-SY5Y and C13NJ cells were grown in 380 
DMEM supplemented with 10% fetal calf serum (FCS) and 4 mM glutamine. HepG2 were grown in 381 
MEM + GlutaMAX™-I (Gibco) containing 10% FCS. RPE-1 cells were grown in DMEM/F12 + 382 
GlutaMAX™-I (Gibco) containing 10% FCS.  383 
Microscopy  384 
Immunofluorescence and microscopy of both living and fixed cells (including fluorescence recovery 385 
after photobleaching) were carried out essentially as described previously 23.  386 
Cloning and expression of GFP-Sec16B 387 
GFP-Sec16B was generated by PCR using primers designed according to the sequences of Sec16B 388 
(GenBank accession AB063357) and cloned into pLVX-Puro (Clontech). Virus was produced and cells 389 
transduced according to the manufacturer’s recommended protocols. Stably expressing cells were 390 
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selected using puromycin. Clones were not generated – all experiments were on mixed populations. 391 
Transient transfections were achieved using Lipofectamine 2000 (Invitrogen, Paisley, UK) according 392 
to the manufacturer’s instructions). Truncation mutants were generated using PCR and verified by 393 
DNA sequencing (MWG Eurofins).  394 
RNA interference 395 
Transfection of siRNA duplexes was done using a modified calcium phosphate method as described 396 
previously 38. siRNA duplexes were synthesized by Eurofins/MWG Biotech with the following 397 
sequences with the exception of the smartPool duplexes which were from Dharmacon/Pierce and 398 
the two from Ambion as indicated. GL2 5’-CGU ACG CGG AAU ACU UCG A-3’; lamin A/C: 5’-CUG GAC 399 
UUC CAG AAG AAC A-3’; Sec16A UTR: 5’-GCA GCU CUG GAA CUU AGU A-3’; Sec16B Smartpool: 5’-400 
GGA CGG AAA UCU UCG AGU A-3’; 5’-GCU GCU AGA CCA CGA AGU A-3’; 5’-CGA AGG UGG UUA UCG 401 
CAA U-3’; 5’-CGA UCG AAG CCC ACC AAG A-3’; Sec16B #1 : 5’-UGG AGG UUA UUC UUA AUG A-3’; 402 
Sec16B #2 : 5’-AUC UUC GAG UAG UGU CAG A-3’; Sec16B “G”: 5’-UAG UGA AUU UCU CCA CGA UCU 403 
GCG C-3’ (as described in 21); Sec16B  UTR : 5’-UGA GUG CCU GAU AUU GUU A-3’; Sec16B 1: 5’-CGA 404 
AGG UGG UUA UCG CAA U-3’; ( #s40166, Ambion Applied Biosystems, UK); Sec16B 2: 5’-GGA GGA 405 
AUA UGC UUA UGG A-3’; (#s40165, Ambion Applied Biosystems, UK).  406 
Q-PCR 407 
The primers for the Q-PCR of Sec16A and Sec16B were designed so that a Q-PCR product of ~ 250 408 
bp, ideally spanning two exons, is amplified. Primer sequences were as follows: Forward primer for 409 
Q-PCR of RNA Polymerase 2: 5'-TAT CTG CAC TGC CAA GAC TGA-3'; Reverse primer for Q-PCR of RNA 410 
Polymerase 2: 5'-CCA CAA TGC TCA TGC CTT CTT TCA-3'; Forward primer for Q-PCR of Sec16A: 5’-CAC 411 
TCC CTG GCT CTG AAC TC-3’; Reverse primer for Q-PCR of Sec16A: 5’-AAT CCT CCC TAG CCT TGA GC-412 
3’; Forward primer for Q-PCR of Sec16B 5’-TCA GCC TGT GTC TGG AGT TG-3’; Reverse primer for Q-413 
PCR of Sec16B: 5’-CGG TAA TCT TCG TGC CAG AT-3’. Q-PCR was carried out as described in 39.  414 
Protein interactions and mass spectrometry 415 
Cells were lysed and GFP-tagged proteins isolated using GFP-Trap® beads (Chromotek) according the 416 
manufacturers protocol. For a large scale immunoprecipitation, HeLa GFP-Sec16B cells were plated 417 
on two 15 cm tissue culture dishes, the cells lysed in 300 µl lysis buffer and the lysate of the two 418 
plates pooled together. As a negative control, HeLa cells transfected with pEGFP-C2 were used. The 419 
cleared lysate was subsequently incubated for 2 h at 4ºC with 30 µl of equilibrated GFP-Trap® beads 420 
to allow binding of GFP fusion protein. The beads where then washed four times 5 min with 500 µl 421 
of dilution buffer and resuspended in 150 µl 2x sample buffer. The beads were boiled for 10 min at 422 
95ºC and 20 µl of sample separated by SDS-PAGE on a 5% and 15% gel. Proteins were subsequently 423 
stained using SYPRO® Ruby and protein bands visualized using the Typhoon™ scanner 9400 (GE 424 
Healthcare). Proteins, which only bound to the protein of interest but not to the GFP control, were 425 
subsequently determined. These proteins were extracted from the gel, prepared for and analyzed by 426 
MS/MS spectrometry by Kate Heesom (Proteomics Facility, University of Bristol). 427 
428 
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Figure Legends: 539 
 540 
Figure 1: Sec16B expression is undetectable in a panel of cell lines. HeLa cells were transfected with 541 
GFP-Sec16B, lysed 16 hours after transfection. Lysates were also produced from HepG2, RPE-1, 542 
NHDF, SH-SY5Y, C13NJ, and HeLa cells. The cell lysates were separated by SDS-PAGE and 543 
immunoblotted with the antibodies (A) anti-Sec16B (393-408), (B) anti-Sec16B (883-897), and (C) 544 
anti-Sec16B (996-1010). All three antibodies detected GFP-Sec16B (A, B and C lane 1 #). No 545 
endogenous Sec16B could be detected in any of the cell types. The bands at ~ 100 kD recognized by 546 
anti-Sec16B (883-897) and anti-Sec16B (393-408) are non-specific bands (A and B, arrows) since they 547 
could not be depleted using siRNA (not shown). (D-F) HeLa cells were transfected with GFP-Sec16B, 548 
methanol fixed and stained with the antibodies (D) anti-Sec16B (393-408), (E) anti-Sec16B (883-897), 549 
and (F) anti-Sec16B (996-1010). The antibodies anti-Sec16B (883-897) and anti-Sec16B (996-1010) 550 
both detected overexpressed GFP-Sec16B and clearly labelled GFP-Sec16B marked ERES (E and F, 551 
zoom, arrows). Scale bar = 20 µm. (G-J) NHDF and C13NJ cells were methanol fixed and double 552 
labelled with the antibodies anti-Sec16B (883-897) or anti-Sec16B (996-1010) (green) and anti-553 
Sec31A or anti-Sec24C (red). (G) Anti-Sec16B (883-897) detected some puncta in NHDF cells, these 554 
did not localize in proximity of Sec31A (zoom, arrows). (H) Anti-Sec16B (996-1010) recognized small 555 
puncta in NHDF cells. These were distinct from Sec24C (zoom, arrows). (I, J) Anti-Sec16B (883-897) 556 
and anti-Sec16B (996-1010) labelling was cytosolic in C13NJ cells. Scale bar = 20 µm. 557 
Figure 2: Validation of Sec16B siRNAs. RPE1 cells stably expressing GFP-Sec16B were transfected 558 
with siRNA duplexes targeting Sec16B (Sec16B “G” as used in 21, Sec16B UTR targeting the 3’ 559 
untranslated region, Sec16B #1 and Sec16B #2 targeting the coding sequence). GFP-Sec16B is 560 
knocked down efficiently with all siRNAs except Sec16B UTR which only targets the endogenous 561 
Sec16B. 562 
Figure 3: Depletion of Sec16B in HeLa cells does not affect the localization of Sec24C or ERGIC-53, 563 
nor can GFP-Sec16B functionally replace Sec16A. (A-D) Cells transfected with (A) a control siRNA 564 
duplex or those targeting (B) Sec16A, (C) Sec16B or (D) both isoforms as indicated were methanol 565 
fixed and processed for immunofluorescence to detect Sec24C and ERGIC-53. Boxed regions show 2x 566 
enlargements. Note the loss of peripheral puncta labelled with Sec24C or ERGIC-53 when cells are 567 
depleted of Sec16A but not when depleted of Sec16B. Bars = 20 µm. (E) Depletion of Sec16A in HeLa 568 
and HeLa GFP-Sec16B cells. HeLa or HeLa GFP-Sec16B cells were transfected with siRNA duplexes as 569 
follows: GL2 (non-targeting control), lamin A/C (positive control), Sec16A UTR (targeting the 3’ 570 
untranslated sequence of Sec16A 13). Cells were lysed 72 hours after transfection. Efficient depletion 571 
of Sec16A could be detected in HeLa control cells and HeLa GFP-Sec16B cells (top row, lane 3 and 6). 572 
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A slight reduction of GFP-Sec16B can be observed in HeLa GFP-Sec16B cells depleted of Sec16A 573 
(second row, lane 6). Lamin A/C knockdown was efficient (third row, lane 2 and 5). α-tubulin was 574 
used as a loading control (bottom row). (F-I) GFP-Sec16B HeLa cells were methanol fixed 72 hours 575 
after transfection with the non-targeted control GL2 and Sec16A UTR. (F, G) Cells were stained for 576 
Sec31A. In Sec16A depleted cells (G) a reduction of Sec31A positive ERES could be observed 577 
compared to controls (F, note boxed 2x enlargements). (H, I) Immunolabelling revealed that ERGIC-578 
53 was relocalized to the ER in Sec16A depleted cells (I) compared to controls (H). Expression of GFP-579 
Sec16B appeared lower in Sec16A depleted cells (G and I, bottom panels, zoom). Scale bars = 20 µm. 580 
Single optical Z-sections are shown.  581 
Figure 4: Localization of GFP-Sec16B relative to other ERES and ERGIC components. (A) GFP-Sec16B 582 
shows a high degree of overlap with endogenous Sec16A. (B, C) GFP-Sec16B localizes offset from (B) 583 
ERGIC-53 and (C) COPI which label the ERGIC. Bars = 20 µm, 200 nm in zoom a, 500 nm in zoom b 584 
and c. (D) Live cell imaging showed a minor population of stably transfected cells show a nuclear 585 
localization of GFP-Sec16B. GFP-Sec16B could be found throughout the nucleus showing some 586 
brighter puncta. (E, F) In methanol fixed cells punctate structures within the nucleus could be 587 
observed. Labelling with an anti-Coilin (E) and anti-PML (F) antibody showed that the puncta were 588 
distinct from Coilin and PML.  Scale bar = 20 µm (10 µm in zooms). Single optical Z-sections are 589 
shown.   590 
Figure 5: Requirements for localization of GFP-Sec16B to ERES. (A) Schematic of deletion constructs 591 
used. Full-length GFP-Sec16B was used as a control. (B) GFP-tagged tER localization domain 592 
constructs of Sec16B were transfected into HeLa cells. Live cell imaging showed that only full-length 593 
GFP-Sec16B localized to ERES. None of the deletion constructs localized to ERES, all deletion 594 
constructs were cytosolic and nuclear localized. (C) Following methanol fixation, GFP-tagged tER 595 
localization constructs were primarily cytosolic and the nuclear pool was mainly extracted. Very few 596 
cells (<5%) showed a diffuse punctate pattern (see # for example). Scale bar = 20 µm.   597 
Figure 6: GFP-Sec16B interacts with Sec16A and Sec13. GFP-Sec16B and proteins bound to Sec16B 598 
were extracted from whole cell lysate using GFP-Trap®. The beads fraction was loaded on a 15% (A) 599 
and 5% (B) gel and subjected to SDS-PAGE to separate the proteins bound to GFP-Sec16B. The 600 
proteins were stained using SYPRO® Ruby. Three distinct protein bands were extracted from the 15% 601 
gel (1, 2 and 3, arrows), the proteins digested and analyzed by MS/MS spectrometry. The proteins 602 
were then identified by blast search against a human database. GFP-Sec16B migrated at ~ 144 kD (B, 603 
#). (C) Identification of interaction partners of GFP-Sec16B by immunoprecipitation and 604 
immunoblotting. HeLa GFP-Sec16B cells and HeLa control cells expressing GFP were lysed. GFP and 605 
GFP-Sec16B were subsequently bound to GFP-Trap® beads. 1% of input and unbound fraction and 606 
19 
 
20% of beads were loaded. Probing with an anti-GFP antibody revealed some degradation of GFP-607 
Sec16B during the sample analysis. Western blotting revealed that GFP-Sec16B (~ 144 kD, #) and the 608 
GFP control were bound efficiently to the GFP-Trap® beads (top row, lane 2 and 5). GFP-Sec16B 609 
bound to Sec13 (second row, lane 5) and Sec16A (bottom row, lane 5), but not to Sec31A (third row, 610 
lane 5). 611 
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